Maxwell is an antitrust correspondent for MLex’s Washington, DC bureau. He started with MLex North America as a general assignment reporter. He is a recent graduate of the University of Missouri School of Journalism. Prior to reporting in DC, he covered the Missouri General Assembly for the Columbia Missourian and interned in MLex’s Brussels, Belgium bureau.
Selected Insights by Max
Their stories are different, but Kim and Ullings underscore the difficulty antitrust conspirators face once they are targeted by US law enforcement.
United Therapeutics, Smiths Medical restricted syringe shipments to keep patients on branded lung treatment, court filing allegesUnited Therapeutics and Smiths Medical restricted shipments to pharmacies of specialized syringes that deliver a life-saving drug used to treat a serious lung condition, according to allegations in confidential material from a court filing in an antitrust suit.
Apple's handling of parental control apps draws scrutiny abroad as US ramps up examination of Big TechAs US regulators gear up to examine competition among technology companies, international jurisdictions have identified a potential vulnerability for Apple: parental control apps.
After nearly two years of service, the US Department of Justice’s international antitrust policy chief left his post yesterday to return to his professorship at Notre Dame Law School. In his wake are commitments from over 70 — and counting — foreign competition agencies to adhere to minimum due-process standards he played a key role in developing.
Surescripts, the US's largest e-prescription network, has been sued by the US Federal Trade Commission, which alleged that the company monopolized the market by including loyalty provisions in its contracts with customers since 2009.